Greenebaum Comprehensive Cancer Center — Baltimore, Maryland

Greenebaum Comprehensive Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Greenebaum Comprehensive Cancer Center has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Lymphoma, Mantle-Cell, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma.

Sponsors: Loxo Oncology, Inc., Pfizer, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Greenebaum Comprehensive Cancer Center?

Greenebaum Comprehensive Cancer Center has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Greenebaum Comprehensive Cancer Center conducted?

Greenebaum Comprehensive Cancer Center has 4 clinical trials on record, with 3 currently active. Their work covers Lymphoma, Mantle-Cell, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma.

Is Greenebaum Comprehensive Cancer Center accredited by Crixeo Health?

Greenebaum Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Greenebaum Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.